Although 225Ac-PSMA had high antitumor efficacy but it is also worth noting that such alpha emitters have higher uptake in the salivary glands, leading to more severe xerostomia and dose-limiting toxicity as compared to 177Lu-PSMA-617 [66]. Here, FOLH1 is linked to xerostomia.